Diabetic retinopathy - ocular complications of diabetes mellitus

Published on Apr 15, 2015in World Journal of Diabetes3.247
· DOI :10.4239/WJD.V6.I3.489
Martin M. Nentwich16
Estimated H-index: 16
(LMU: Ludwig Maximilian University of Munich),
Michael W. Ulbig33
Estimated H-index: 33
(LMU: Ludwig Maximilian University of Munich)
Sources
Abstract
In industrialized nations diabetic retinopathy is the most frequent microvascular complication of diabetes mellitus and the most common cause of blindness in the working-age population. In the next 15 years, the number of patients suffering from diabetes mellitus is expected to increase significantly. By the year 2030, about 440 million people in the age-group 20-79 years are estimated to be suffering from diabetes mellitus worldwide (prevalence 7.7%), while in 2010 there were 285 million people with diabetes mellitus (prevalence 6.4%). This accounts for an increase in patients with diabetes in industrialized nations by 20% and in developing countries by 69% until the year 2030. Due to the expected rise in diabetic patients, the need for ophthalmic care of patients (i.e., exams and treatments) will also increase and represents a challenge for eye-care providers. Development of optimized screening programs, which respect available resources of the ophthalmic infrastructure, will become even more important. Main reasons for loss of vision in patients with diabetes mellitus are diabetic macular edema and proliferative diabetic retinopathy. Incidence or progression of these potentially blinding complications can be greatly reduced by adequate control of blood glucose and blood pressure levels. Additionally, regular ophthalmic exams are mandatory for detecting ocular complications and initiating treatments such as laser photocoagulation in case of clinical significant diabetic macular edema or early proliferative diabetic retinopathy. In this way, the risk of blindness can considerably be reduced. In advanced stages of diabetic retinopathy, pars-plana vitrectomy is performed to treat vitreous hemorrhage and tractional retinal detachment. In recent years, the advent of intravitreal medication has improved therapeutic options for patients with advanced diabetic macular edema.
📖 Papers frequently viewed together
201216.02Diabetes Care
36 Authors (Joanne W.Y. Yau, ..., Tien Yin Wong)
1,948 Citations
1,532 Citations
606 Citations
References54
Newest
#1Adam Boretsky (UTMB: University of Texas Medical Branch)H-Index: 10
#2Praveena Gupta (Visual Sciences)H-Index: 11
Last. Massoud MotamediH-Index: 57
view all 8 authors...
AbstractPurpose: To investigate the effects of nicotine on retinal alterations in early-stage diabetes in an established rodent model.Materials and Methods: Sprague–Dawley rats were examined using a combination of confocal scanning laser ophthalmoscopy and spectral domain optical coherence tomography to determine changes in retinal structure in response to nicotine exposure, diabetes and the combined effects of nicotine and diabetes. Diabetes was induced by a single injection of 65 mg/kg strepto...
14 CitationsSource
Abstract One of the major complications in patients with diabetes is diabetic retinopathy (DR), a leading cause of blindness worldwide. It causes visual impairment and finally blindness, a result of long-term accumulated damage to the small blood vessels in the retina. It takes several years before any clinical symptoms of retinopathy appear in diabetic patients. Consequently, glycemic control, blood pressure and lipid-lowering therapy have all shown benefits in reducing the incidence and progre...
64 CitationsSource
#1Frank D. Verbraak (UvA: University of Amsterdam)H-Index: 24
Diabetic vasculopathy is still, despite all efforts to treat its late complications, the leading cause of blindness among the working-age adults in the Western world, and in the developing countries, a similar situation is created due to the catching up in welfare and in its wake an identical unhealthy diabetes-promoting lifestyle (1). The definition of diabetic retinopathy is based on observation of vascular changes. The first recognizable vascular abnormalities are microaneurysms and small hem...
8 CitationsSource
#1David S. BoyerH-Index: 58
#2Young Hee Yoon (Asan Medical Center)H-Index: 30
Last. Scott M. Whitcup (Allergan)H-Index: 25
view all 10 authors...
Purpose To evaluate the safety and efficacy of dexamethasone intravitreal implant (Ozurdex, DEX implant) 0.7 and 0.35 mg in the treatment of patients with diabetic macular edema (DME). Design Two randomized, multicenter, masked, sham-controlled, phase III clinical trials with identical protocols were conducted. Data were pooled for analysis. Participants Patients (n = 1048) with DME, best-corrected visual acuity (BCVA) of 20/50 to 20/200 Snellen equivalent, and central retinal thickness (CRT) of...
535 CitationsSource
#1Muneeswar Gupta Nittala (SC: University of Southern California)H-Index: 21
#2Pearse A. KeaneH-Index: 55
Last. Srinivas R. SaddaH-Index: 79
view all 4 authors...
Proliferative diabetic retinopathy (PDR) is a serious complication of diabetes and is a leading cause of legal blindness and visual impairment in the working age population of western countries.1–3 In the United States (US), Latinos have a high prevalence of diabetes mellitus (DM) and appear to be at high risk for microvascular complications, including DR.2,4–6 In addition, the Latino population is the largest and fastest growing minority group in the US (with 50.5 million people, accounting for...
21 CitationsSource
Vascular endothelial growth factor (VEGF) plays a pivotal role in the development of diabetic macular edema (DME), the leading cause of vision loss among working-aged individuals. A decade of clinical trials demonstrated that drugs that bind soluble VEGF restore the integrity of the blood-retinal barrier, resolve macular edema, and improve vision in most patients with DME. Four drugs (pegaptanib, ranibizumab, bevacizumab, and aflibercept) effectively treat DME when administered by intravitreal i...
42 CitationsSource
#1Troels Brynskov (Copenhagen University Hospital)H-Index: 7
#2Henrik KempH-Index: 5
Last. Torben Lykke SørensenH-Index: 27
view all 3 authors...
Background: Intravitreal injection has become a common procedure worldwide. A rare, but sight threatening, complication is bacterial endophthalmitis that has a poor visual prognosis. To identify practices that minimize the risk of endophthalmitis, the setting of a Danish University hospital is described. Methods: A review of the intravitreal injection database of the department. All injections were performed in a positive pressure ventilated operating room under sterile conditions. The treating ...
38 CitationsSource
#1Martin M. Nentwich (LMU: Ludwig Maximilian University of Munich)H-Index: 16
Last. Herminia Miño de KasparH-Index: 23
view all 6 authors...
Purpose: To report the incidence, clinical features, microbiologic culture results, management and visual outcome of patients with endophthalmitis after intravitreal injections (IVTs). Methods: This retrospective chart review included all patients receiving IVTs between January 2005 and July 2012. Cases of suspected and confirmed endophthalmitis after IVT were identified and reviewed. Results: A total of 20,179 IVTs were perfomed during the study period. Six cases of supected endophthalmitis wer...
32 CitationsSource
#1Thomas A. CiullaH-Index: 53
#2Alon Harris (IU: Indiana University)H-Index: 72
Last. Christian P. Jonescu-Cuypers (IU: Indiana University)H-Index: 20
view all 4 authors...
Introduction: Diabetic macular edema (DME) can be treated with intravitreal glucocorticoids, particularly triamcinolone acetonide, dexamethasone (DEX), and fluocinolone acetonide (FA). Areas covered: The pathophysiology of DME includes multiple growth factors such as VEGF and also inflammatory mediators. Glucocorticoids act on DME through multiple pathways, and current research into their efficacy, safety, and therapeutic potential when administered intravitreally is discussed. Conclusion: The i...
32 CitationsSource
#1Steven F. Abcouwer (UM: University of Michigan)H-Index: 14
#2Thomas W. Gardner (UM: University of Michigan)H-Index: 24
Last. Thomas W. Gardner (UM: University of Michigan)H-Index: 46
view all 2 authors...
Diabetic retinopathy (DR) impairs vision of patients with type 1 and type 2 diabetes, associated with vascular dysfunction and occlusion, retinal edema, hemorrhage, and inappropriate growth of new blood vessels. The recent success of biologic treatments targeting vascular endothelial growth factor (VEGF) demonstrates that treating the vascular aspects in the later stages of the disease can preserve vision in many patients. It would also be highly desirable to prevent the onset of the disease or ...
108 CitationsSource
Cited By172
Newest
#1Vladislav O. Soldatov (RAS: Russian Academy of Sciences)H-Index: 3
#2Michail S. Kukharsky (RSMU: Russian National Research Medical University)H-Index: 11
Last. Alexey V. DeykinH-Index: 8
view all 5 authors...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease resulting in a gradual loss of motor neuron function. Although ophthalmic complaints are not presently considered a classic symptom of ALS, retinal changes such as thinning, axonal degeneration and inclusion bodies have been found in many patients. Retinal abnormalities observed in postmortem human tissues and animal models are similar to spinal cord changes in ALS. These findings are not dramatically unexpected because ret...
Source
We rely on vision more than on any other sense to obtain information about our environment. Hence, the loss or even impairment of vision profoundly affects our quality of life. Diet or food components have already demonstrated beneficial effects on the development of retinal diseases. Recently, there has been a growing interest in resources from marine animals and plants for the prevention of retinal diseases through nutrition. Especially fish intake and omega-3 fatty acids have already led to p...
Source
#1Xin Li (HMU: Harbin Medical University)H-Index: 2
#2Zi-Wei Yu (HMU: Harbin Medical University)H-Index: 2
Last. Hong-Yu Kuang (HMU: Harbin Medical University)H-Index: 1
view all 6 authors...
Microglia, the main immune cell of the central nervous system (CNS), categorized into M1-like phenotype and M2-like phenotype, play important roles in phagocytosis, cell migration, antigen presentation, and cytokine production. As a part of CNS, retinal microglial cells (RMC) play an important role in retinal diseases. Diabetic retinopathy (DR) is one of the most common complications of diabetes. Recent studies have demonstrated that DR is not only a microvascular disease but also retinal neurod...
Source
#2Hou YachenH-Index: 3
view all 4 authors...
Natural astaxanthin exists widely in algae, fungi, shrimp and crab, and, as a strong antioxidant, has potential effects on cardiovascular diseases, cancer, liver diseases and other physical health diseases. The treatment of many diseases involves the body’s signal transduction to regulate the body’s antioxidant defense system and inflammation. Astaxanthin is usually used as a dietary supplement, which plays an antioxidant and anti-inflammatory role in the organism. This article reviews the struc...
Source
#1Shang-Jyh Chiou (National Taipei University of Nursing and Health Science)H-Index: 1
Last. Chi-Jeng Hsieh (OIT: Oriental Institute of Technology)H-Index: 1
view all 5 authors...
AIMS/INTRODUCTION This study investigated whether participation by patients with type 2 diabetes in Taiwan's pay-for-performance (P4P) program and maintaining good continuity of care (COC) with their healthcare provider reduced the likelihood of future complications, such as retinopathy. MATERIALS AND METHODS The analysis used longitudinal panel data for newly diagnosed type 2 diabetes from the National Health Insurance claims database in Taiwan. COC was measured annually from 2003 to 2013, and ...
Source
Choline is essential for maintaining the structure and function of cells in humans. Choline plays an important role in eye health and disease. It is a precursor of acetylcholine, a neurotransmitter of the parasympathetic nervous system, and it is involved in the production and secretion of tears by the lacrimal glands. It also contributes to the stability of the cells and tears on the ocular surface and is involved in retinal development and differentiation. Choline deficiency is associated with...
Source
#1Jia Yu (Bengbu Medical College)
#2Mei Qin (Bengbu Medical College)
Last. Shumin Cui (Bengbu Medical College)
view all 4 authors...
This study aimed to investigate the role of long non-coding RNA (lncRNA) small nucleolar RNA host gene 4 (SNHG4) in diabetic retinopathy (DR). We found that SNHG4 was downregulated in DR. SNHG4 could directly interact with miR-200b, while overexpression of miR-200b did not affect the expression of SNHG4 in human retinal pigment epithelial cells ARPE-19. In contrast, overexpression of SNHG4 led to the upregulation of oxidation resistance 1 (Oxr1), a target of miR-200b. Cell apoptosis analysis sho...
Source
view all 3 authors...
Background. According to a wide range of authors, eye damage caused by diabetes mellitus accounts for 80–90 % of the total number of disorders. The development of mathematical predictive models allows for a more versatile analysis of experimental and clinical data. The purpose of the study was to develop a model for predicting the severity of diabetic retinopathy based on a review of markers of endothelial dysfunction and hypoxia. Materials and methods. We used a streptozotocin model of type 2 d...
Source
#1Zhihui Guo (Fudan University)H-Index: 1
#2Xuqing Wu (Fudan University)H-Index: 4
Last. Wei Fan (Fudan University)H-Index: 7
view all 3 authors...
Abstract Given the sheer increased number of victims per year and the availability of only one effective treatment, acute ischemic stroke (AIS) remains to be one of the most under-treated serious diseases. Diabetes not only increases the incidence of ischemic stroke, but amplifies the ischemic damage, upon which if patients with diabetes suffer from stroke, he/she will confront increased risks of long-term functional deficits. The grim reality makes it a pressing need to intensify efforts at the...
Source
#1Marianne Berdugo (UPMC: Pierre-and-Marie-Curie University)H-Index: 18
#2Kimberley Delaunay (UPMC: Pierre-and-Marie-Curie University)H-Index: 3
Last. Francine Behar-CohenH-Index: 62
view all 18 authors...
Sulfonylureas, widely used as hypoglycemic agents in adults with type 2 diabetes, have neuroprotective effects in preclinical models of central nervous system injury, and in children with neuropsychomotor impairments linked to neonatal diabetes secondary to ATP-sensitive potassium channel mutations. In the human and rodent retina, we show that the glibenclamide-activated channel sulfonylurea receptor 1 (SUR1) is expressed in the retina and enriched in the macula; we also show that it colocalizes...
Source